Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients

• Status: Completed
• Trial end date: 1969-12-31

Summary

The purpose of this study is to evaluate the antihypertensive efficacy and changes of neurohormonal markers of fimasartan and atenolol with exaggerated blood pressure response during exercise in essential hypertensive patients.

• Phase: Phase 4

Details

• Lead Sponsor: Boryung Pharmaceutical Co., Ltd
• Collaborator: Severance Hospital
• Treatments: Antihypertensive Agents; Atenolol